ERP_NN
,_,
a_DT
new_JJ
member_NN
of_IN
the_DT
ets_NN
transcription_NN
factor\/oncoprotein_NN
family_NN
:_:
cloning_NN
,_,
characterization_NN
,_,
and_CC
differential_JJ
expression_NN
during_IN
B-lymphocyte_NN
development_NN
._.

The_DT
ets_NN
gene_NN
family_NN
encodes_VBZ
a_DT
group_NN
of_IN
proteins_NNS
which_WDT
function_VBP
as_IN
transcription_NN
factors_NNS
under_IN
physiological_JJ
conditions_NNS
and_CC
,_,
if_IN
aberrantly_RB
expressed_VBN
,_,
can_MD
cause_VB
cellular_JJ
transformation_NN
._.

We_PRP
have_VBP
recently_RB
identified_VBN
two_CD
regulatory_JJ
elements_NNS
in_IN
the_DT
murine_JJ
immunoglobulin_NN
heavy-chain_NN
-LRB-_-LRB-
IgH_NN
-RRB-_-RRB-
enhancer_NN
,_,
pi_NN
and_CC
microB_NN
,_,
which_WDT
exhibit_VBP
striking_JJ
similarity_NN
to_TO
binding_VBG
sites_NNS
for_IN
ets-related_JJ
proteins_NNS
._.

To_TO
identify_VB
ets-related_JJ
transcriptional_JJ
regulators_NNS
expressed_VBN
in_IN
pre-B_JJ
lymphocytes_NNS
that_WDT
may_MD
interact_VB
with_IN
either_CC
the_DT
pi_NN
or_CC
the_DT
microB_NN
site_NN
,_,
we_PRP
have_VBP
used_VBN
a_DT
PCR_NN
approach_NN
with_IN
degenerate_JJ
oligonucleotides_NNS
encoding_VBG
conserved_VBN
sequences_NNS
in_IN
all_DT
members_NNS
of_IN
the_DT
ets_NN
family_NN
._.

We_PRP
have_VBP
cloned_VBN
the_DT
gene_NN
for_IN
a_DT
new_JJ
ets-related_JJ
transcription_NN
factor_NN
,_,
ERP_NN
-LRB-_-LRB-
ets-related_JJ
protein_NN
-RRB-_-RRB-
,_,
from_IN
the_DT
murine_JJ
pre-B_JJ
cell_NN
line_NN
BASC_NN
6C2_NN
and_CC
from_IN
mouse_NN
lung_NN
tissue_NN
._.

The_DT
ERP_NN
protein_NN
contains_VBZ
a_DT
region_NN
of_IN
high_JJ
homology_NN
with_IN
the_DT
ETS_NN
DNA-binding_JJ
domain_NN
common_JJ
to_TO
all_DT
members_NNS
of_IN
the_DT
ets_NN
transcription_NN
factor\/oncoprotein_NN
family_NN
._.

Three_CD
additional_JJ
smaller_JJR
regions_NNS
show_VBP
homology_NN
to_TO
the_DT
ELK-1_NN
and_CC
SAP-1_NN
genes_NNS
,_,
a_DT
subgroup_NN
of_IN
the_DT
ets_NN
gene_NN
family_NN
that_IN
interacts_VBZ
with_IN
the_DT
serum_NN
response_NN
factor_NN
._.

Full-length_JJ
ERP_NN
expresses_VBZ
only_RB
negligible_JJ
DNA-binding_JJ
activity_NN
by_IN
itself_PRP
._.

Removal_NN
of_IN
the_DT
carboxy_NN
terminus_NN
enables_VBZ
ERP_NN
to_TO
interact_VB
with_IN
a_DT
variety_NN
of_IN
ets-binding_JJ
sites_NNS
including_VBG
the_DT
E74_NN
site_NN
,_,
the_DT
IgH_JJ
enhancer_NN
pi_NN
site_NN
,_,
and_CC
the_DT
lck_NN
promoter_NN
ets_NN
site_NN
,_,
suggesting_VBG
a_DT
carboxy-terminal_JJ
negative_JJ
regulatory_JJ
domain_NN
._.

At_IN
least_JJS
three_CD
ERP-related_JJ
transcripts_NNS
are_VBP
expressed_VBN
in_IN
a_DT
variety_NN
of_IN
tissues_NNS
._.

However_RB
,_,
within_IN
the_DT
B-cell_NN
lineage_NN
,_,
ERP_NN
is_VBZ
highly_RB
expressed_VBN
primarily_RB
at_IN
early_JJ
stages_NNS
of_IN
B-lymphocyte_NN
development_NN
,_,
and_CC
expression_NN
declines_VBZ
drastically_RB
upon_IN
B-cell_NN
maturation_NN
,_,
correlating_VBG
with_IN
the_DT
enhancer_NN
activity_NN
of_IN
the_DT
IgH_NN
pi_NN
site_NN
._.

These_DT
data_NNS
suggest_VBP
that_IN
ERP_NN
might_MD
play_VB
a_DT
role_NN
in_IN
B-cell_NN
development_NN
and_CC
in_IN
IgH_NN
gene_NN
regulation_NN
._.

